Just What Defines Frailty?

The term frailty is frequently used within the geriatrics world to describe patients who are in poor overall health, are vulnerable to the ill effects of a variety of environmental stressors, and are further at high risk for worsened morbidity, worsened disability, and mortality. Clinical experience and clinical research demonstrate that these patients exist, are heavy users of medical services, and have a tough lot in life. Despite our ability to conceptualize and study these patients in the aggregate, a simple consensus definition and criteria for frailty has remained elusive. The elusiveness of the definition of frailty reflects not only the challenges in defining a clinical syndrome where the exact etiology and pathophysiology are unknown but also the challenges of defining the boundaries of a syndrome that has medical, functional, and social components. The work of Mitnitski et al. in this issue adds to this debate. They present data from 11 clinical cohorts with 36,424 patients and examine the relationship between a frailty index and age and mortality. The frailty index is a measure that converts the percentage of deficits present or absent in a particular patient into an index score that varies between 0 and 1, with 0 reflecting no deficits and 1 the presence of all deficits. This measure was previously developed and validated on cohorts from Canada alone, so a major goal of this study was to determine the extent to which the frailty index can be generalized to other populations. To accomplish this goal, they used data from longitudinal studies of older patients drawn from Canada, Australia, Sweden, and the United States. They determined frailty index scores for the patients in the cohorts using primary data from the underlying studies. Because the primary data collected from each study was somewhat different, the deficits examined in each cohort vary. They include data from institutional and disease-specific (cardiovascular disease and breast cancer) cohorts for comparison. They find that the frailty index score correlates strongly with age for men and women in the general cohorts but not the disease-specific or institutional cohorts. The importance of the frailty index score is its strong association with mortality. Increasing frailty index scores lead to an exponential increase in mortality rate, and this association holds true for men and women, with women having a slightly lower death rate for any given score. An important point to bear in mind about the frailty index is that it includes not only physiological problems, such as lack of strength or stamina, but also disease-related, psychological, and social problems. It is the inclusion of these additional dimensions in the frailty index that puts the frailty index at odds with findings of other groups who have defined frailty in more-limited terms. For example, a recent review defined frailty in physiological terms independent of comorbid illnesses and disability, with frailty representing the decline in physiological constitution due to aging and disease. The comorbid illnesses present in many frail patients and the disability resulting from illness and frailty are developed as separate concepts that interact with physical frailty but remain separate. These ideas are an extension of prior work that began to reframe frailty as a biological syndrome characterized by declines in physiological reserves and difficulty in coping with stressors. In contrast, Mitnitski et al. opt to take a broad view of frailty and include a range of comorbid illnesses, measures of disability, and social and psychological issues into their frailty index. The issue of whether frailty is simply defined by physical manifestations of vulnerability or should have a broader definition appears to be the crux of the current debate. Considering social and psychological issues, disability, and medical illnesses as parts of frailty is conceptually simpler and more holistic than considering them separately. As has recently been pointed out, this holistic approach is consistent with the principles of geriatric medicine practice and offers the potential to capture the full effect of frailty. It is appealing to think that a patient who has not only physical frailty but also depression and functional dependence would be ‘‘frailer’’ and have a worse prognosis than one who lacks these problems. In the frailty index developed by Mitnitski et al., this patient would be clearly identified as more frail. Nevertheless, could frailty simply be physical, with comorbid illnesses and disability being linked but independent entities? Work in experimental animals, such as mice, fruit flies, and worms, demonstrates a component of physical decline during aging. For example, in the nematode Caenorhabditis elegans, dramatic declines in muscle mass and mobility as well as multiple physiological parameters accompany aging. These declines are not uniform between genetically identical individuals of the same age in a population; instead there is significant variation that likely reflects some of the random effects of organismal aging. Just as in humans, physical frailty in these experimental animals has prognostic implications. The development and progression of frailty identifies the individuals in the population who are at high risk for short-term mortality. Additionally, genetic mutations or dietary DOI: 10.1111/j.1532-5415.2005. 00510.x